Scholars Central

Short communicationPublished 11 May 2021

Immunohistochemical indicatotrs of Breast Lesionâ?? A one year case study

Authors: Prajwala Nagaraju, Nandini Manoli

Journal of Oncology Translational Research

Volume 7 · Issue 4 · Pages 1

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Breast cancer has ranked number one cancer among Indian females with age adjusted rate as high as 25.8 per 100,000 women and mortality 12.7 per 100,000 women. Diagnosis of Breast lesion has leaped rapidly from FNAC to molecular methods .In some institutes, the best possible cost effective diagnosis is given, whereas in others, molecular studies are done to provide the diagnosis . Immunohistochemical markers like ER, PR , Her2 neu, growth factor receptor -2, Ki- 67, progesterone receptor and p53 are used in breast cancer. Most commonly used among them are ER, PR and Her2 neu , which have array of use in subtyping , treatment and determining prognosis. ER(Estrogen receptor) serves dual roles in breast cancer by predicting favorable disease outcome and by facilitating tumor progression. Up-regulation of ER and/ or the selection of specific ER mutations are early events important for facilitating tumor progression. Along with estrogen receptor (ER), HER-2 is an important gene for molecular targeting treatment . As compared with HER2-negative tumors, HER2-positive breast cancer is aggressive subtype that demonstrates unique epidemiological, clinical, and prognostic differences with poor response to standard chemotherapy regimens. The HER2 gene amplification in the breast cancer is closely related to tumor-cell multiplication ,invasion ,high mitotic count and positive-lymph node metastases, resulting in focal progression and distant metastases leading to adverse survival outcome. Our study aims at correlating Her2 Neu with ER status, mitotic count , lymph node status, lymphovascular invasion.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Oncology Translational Research.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Oncology Translational Research
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Prajwala Nagaraju”
  • BylineArticles whose byline prints “Nandini Manoli”